CSS »

Adaptimmune Therapeutics shares owned by CSS

Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by CSS from 13F filings

Historical chart of CSS investment in Adaptimmune Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adaptimmune Therapeutics held by CSS consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptimmune Therapeutics by CSS

Quarter filed Position value Share count Share price at filing
2023-12-31 $24k 31k 0.79
2023-09-30 $71k 91k 0.78
2023-06-30 $84k 91k 0.93